Galenica AG/€GALE
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Galenica AG
Galenica AG is a healthcare company based in Switzerland, with a core focus on the health and pharmacy sector. The company operates through two main segments: Health & Beauty and Services. The Health & Beauty segment includes the operation of pharmacies and the distribution of health products, while the Services segment provides logistics and related services for the Swiss healthcare sector. Founded in 1927, Galenica has evolved to become a key player in the Swiss market with a comprehensive network and infrastructure that facilitate efficient healthcare distribution. Its strategic positioning is enhanced by its extensive logistics capabilities and strong presence within Switzerland, headquartered in Bern.
Ticker
€GALE
Sector
Primary listing
XGAT
Employees
6,577
Headquarters
Bern, Switzerland
Website
Galenica AG Metrics
BasicAdvanced
€4.6bn
23.18
€3.94
0.28
€2.71
1.48%
Price and volume
Market cap
€4.6bn
Beta
0.28
52-week high
€105.30
52-week low
€88.85
Average daily volume
55k
Dividend rate
€2.71
Financial strength
Current ratio
1.147
Quick ratio
0.688
Long term debt to equity
52.386
Total debt to equity
70.088
Dividend payout ratio (TTM)
63.56%
Interest coverage (TTM)
16.85%
Profitability
EBITDA (TTM)
290.786
Gross margin (TTM)
12.17%
Net profit margin (TTM)
4.37%
Operating margin (TTM)
5.47%
Effective tax rate (TTM)
17.31%
Revenue per employee (TTM)
€684,950
Management effectiveness
Return on assets (TTM)
4.45%
Return on equity (TTM)
12.11%
Valuation
Price to earnings (TTM)
23.179
Price to revenue (TTM)
1.011
Price to book
2.84
Price to tangible book (TTM)
61.92
Price to free cash flow (TTM)
17.178
Free cash flow yield (TTM)
5.82%
Free cash flow per share (TTM)
5.322
Dividend yield (TTM)
2.97%
Forward dividend yield
1.48%
Growth
Revenue change (TTM)
5.48%
Earnings per share change (TTM)
-1.11%
3-year revenue growth (CAGR)
4.86%
10-year revenue growth (CAGR)
3.57%
3-year earnings per share growth (CAGR)
3.09%
10-year earnings per share growth (CAGR)
8.38%
3-year dividend per share growth (CAGR)
4.35%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs